Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -158,722 | -72,119 | -284,126 | -198,392 | -121,484 |
| Depreciation Amortization | -604 | -3,908 | -3,547 | -2,914 | -1,455 |
| Accounts receivable | -26,820 | -12,676 | -9,391 | -6,170 | -4,423 |
| Accounts payable and accrued liabilities | 2,058 | 2,958 | 3,189 | 6,529 | 10,439 |
| Other Working Capital | -38,465 | -14,951 | -6,353 | -10,124 | 345 |
| Other Operating Activity | 44,911 | 17,847 | 40,684 | 24,711 | 9,485 |
| Operating Cash Flow | $-177,642 | $-82,849 | $-259,544 | $-186,360 | $-107,093 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -689 | -566 | -325 | -324 | -15 |
| Purchase Of Investment | -552,782 | -826,713 | -224,575 | -155,194 | -119,899 |
| Sale Of Investment | 268,665 | 505,244 | 505,244 | 384,353 | 284,977 |
| Investing Cash Flow | $-284,806 | $-322,035 | $280,344 | $228,835 | $165,063 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 447,318 | 441,814 | 11,519 | 3,605 | 3,014 |
| Financing Cash Flow | $447,318 | $441,814 | $11,519 | $3,605 | $3,014 |
| Beginning Cash Position | 93,765 | 93,765 | 61,446 | 61,446 | 61,446 |
| End Cash Position | 78,635 | 130,695 | 93,765 | 107,526 | 122,430 |
| Net Cash Flow | $-15,130 | $36,930 | $32,319 | $46,080 | $60,984 |
| Free Cash Flow | |||||
| Operating Cash Flow | -177,642 | -82,849 | -259,544 | -186,360 | -107,093 |
| Capital Expenditure | -689 | -566 | -325 | -324 | -15 |
| Free Cash Flow | -178,331 | -83,415 | -259,869 | -186,684 | -107,108 |